<DOC>
	<DOC>NCT02449941</DOC>
	<brief_summary>The purpose of this study is to know the distribution of HP in stomach before use of PPI, during use of PPI, and after stop of PPI.</brief_summary>
	<brief_title>Helicobacter Pylori and Proton Pump Inhibitor</brief_title>
	<detailed_description>Endoscopy and biopsy will be performed to investigate the distrubition of HP before, during, and after using PPI.</detailed_description>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>1. Patients who are indicated to endoscopic resection due to gastric neoplasm 2. Aged between 19 to 65 years 3. Informed consent 1. Previous history of HP eradication 2. Previous history of PPI use within 6 months 3. No HP infection</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Stomach Neoplasms</keyword>
	<keyword>proton pump inhibitor</keyword>
	<keyword>endoscopic submucosal dissection</keyword>
	<keyword>Helicobacter pylori</keyword>
	<keyword>Gastritis, Atrophic</keyword>
</DOC>